011HO11778 ALTAROBSON

Print/PDF
Registration Name BOMAZ ALTAROBSON-ET
Registration Number HOUSA000073953484
Primary NAAB Code 011HO11778
Secondary Code(s) 511HO11778
Status Inactive
Controller Name Alta Genetics (11)
Date of Birth 8/24/2015
aAa 132
DMS 345,135
GFI 12.1%
Genetic Codes * TP TV TL TY TD TC
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T
Sire EDG RUBICON-ET
MGS ROYLANE BOOKEM BOB 5170-ET
Beta Casein A2A2
Kappa Casein BB
Beta Lactoglobulin AA
INDEXES
NM$ 126, 96% R CM$ 185
NM Percentile 21% FM$ -15
GTPI 2628 GM$ 152
PRODUCTION TRAITS
8034 Dtrs 829 herds 71 % US 99% R
Milk -1119 Fat, % 11 , +0.23%
SCS 2.92, 99% R Protein, % 8 , +0.18%
Feed Saved -148 , 82% R Milking Speed 6.45 , 95% R
Health & Fertility
Productive Life 1.2      99% R Mastitis 1.2      99% R
Heifer Livability -1.7       94% R Metritis 1.3      98% R
Livability 1.2      98% R D. Abom 0.6      99% R
DPR 2.6      99% R Ketosis 1.5      98% R
FSC 6.9      99% R R. Placenta 0.1      98% R
HCR 4.8      99% R Milk Fever 0.1      95% R
CCR 2.7      99% R
SCR -        -
DIA -0.5      83% R
RSP -0.4      94% R
Calving Traits
Sire CE 1.3      99% R 12003 Obs
Daughter CE 1.3      98% R 5529 Obs, 4684 Dtrs
Sire SB 3.0      98% R 11144 Obs
Daughter SB 2.8      98% R 5349 Obs, Dtrs
Gestation Length -1.8      99% R 269 Obs, 8996 Dtrs
Early First Calving 7.6      99% R 334 Obs, 5166 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1055 Dtrs 251 herds 98% R
PTA Type -0.67 UDC -1.42
HCC -0.58 BWC 2.23
FLC -0.10
Linear Traits
Stature 0.67
Tall
Strength 1.41
Strong
Body Depth 0.09
Deep
Dairy Form -2.10
Closed
Rump Angle -0.25
Flat
Thurl Width 0.40
Flat
Rear Legs-Side View 0.40
Wide
Rear Legs-Rear View 0.63
Straight
Foot Angle -0.11
Low
Feet & Legs Score -0.08
Low
F.U. Attachment 0.83
Curved
Rear Udder Height -1.93
Low
Rear Udder Width -1.56
Narrow
Udder Cleft -3.01
Weak
Udder Depth 0.63
Straight
Front Teat Placement -0.64
Wide
Rear Teat Placement -1.85
Wide
Teat Length 0.78
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO